<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
PYPD
PolyPid
$
()


  • PolyPid files $200M ordinary shares offering

    7/2/2024 - 16:11pm
  • PolyPid hosts KOL call, provides update on ongoing SHIELD II Phase 3 trial

    6/18/2024 - 07:17am
  • PolyPid to hold a conference call

    6/17/2024 - 09:55am
  • PolyPid to hold a conference call

    6/17/2024 - 04:55am
  • PolyPid to hold a conference call

    6/14/2024 - 16:42pm
  • option delistings on June 3rd

    6/3/2024 - 08:30am
  • PolyPid reports Q1 EPS ($1.37), consensus ($1.41)

    5/8/2024 - 07:29am
  • PolyPid announces enrollment in 200th patient in SHIELD II Phase 3 trial

    4/30/2024 - 07:16am
  • PolyPid price target lowered by $2 at H.C. Wainwright, here's why

    2/15/2024 - 06:16am
  • PolyPid reports Q4 EPS ($3.97), consensus ($3.58)

    2/14/2024 - 07:04am
  • PolyPid enrolls 100th patient in SHIELD II phase 3 trial

    2/12/2024 - 07:12am
  • PolyPid files to sell 6.74M ordinary shares for holders

    2/1/2024 - 17:28pm
  • PolyPid reports Q3 EPS ($3.40), consensus ($4.16)

    11/8/2023 - 07:06am
  • PolyPid appoints Nurit Tweezer-Zaks to board of directors

    11/7/2023 - 07:43am
  • PolyPid price target raised to $10 from $2.50 at Barclays

    10/23/2023 - 05:50am
dynamic_feed Breaking News